Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Regular exercise improves asthma control in adults: A randomized controlled trial.

Jaakkola JJK, Aalto SAM, Hernberg S, Kiihamäki SP, Jaakkola MS.

Sci Rep. 2019 Aug 19;9(1):12088. doi: 10.1038/s41598-019-48484-8.

2.

High Nitrogen Removal in a Constructed Wetland Receiving Treated Wastewater in a Cold Climate.

Uusheimo S, Huotari J, Tulonen T, Aalto SL, Rissanen AJ, Arvola L.

Environ Sci Technol. 2018 Nov 20;52(22):13343-13350. doi: 10.1021/acs.est.8b03032. Epub 2018 Nov 5.

PMID:
30358987
3.

Novel Autotrophic Organisms Contribute Significantly to the Internal Carbon Cycling Potential of a Boreal Lake.

Peura S, Buck M, Aalto SL, Morales SE, Nykänen H, Eiler A.

MBio. 2018 Aug 14;9(4). pii: e00916-18. doi: 10.1128/mBio.00916-18.

4.

Resistant ammonia-oxidizing archaea endure, but adapting ammonia-oxidizing bacteria thrive in boreal lake sediments receiving nutrient-rich effluents.

Aalto SL, Saarenheimo J, Mikkonen A, Rissanen AJ, Tiirola M.

Environ Microbiol. 2018 Oct;20(10):3616-3628. doi: 10.1111/1462-2920.14354. Epub 2018 Sep 9.

5.

The influence of oxygen and methane on nitrogen fixation in subarctic Sphagnum mosses.

Kox MAR, Aalto SL, Penttilä T, Ettwig KF, Jetten MSM, van Kessel MAHJ.

AMB Express. 2018 May 5;8(1):76. doi: 10.1186/s13568-018-0607-2.

6.

Sediment diffusion method improves wastewater nitrogen removal in the receiving lake sediments.

Aalto SL, Saarenheimo J, Ropponen J, Juntunen J, Rissanen AJ, Tiirola M.

Water Res. 2018 Jul 1;138:312-322. doi: 10.1016/j.watres.2018.03.068. Epub 2018 Mar 27.

7.

Sub-arcsecond imaging of the water emission in Arp 220.

König S, Martín S, Muller S, Cernicharo J, Sakamoto K, Zschaechner LK, Humphreys EML, Mroczkowski T, Krips M, Galametz M, Aalto S, Vlemmings WHT, Ott J, Meier DS, Fuente A, García-Burillo S, Neri R.

Astron Astrophys. 2017 Jun;602. pii: A42. doi: 10.1051/0004-6361/201630331. Epub 2017 Jun 2.

8.

Microbial Community Response on Wastewater Discharge in Boreal Lake Sediments.

Saarenheimo J, Aalto SL, Rissanen AJ, Tiirola M.

Front Microbiol. 2017 Apr 25;8:750. doi: 10.3389/fmicb.2017.00750. eCollection 2017.

9.

Terrestrial carbohydrates support freshwater zooplankton during phytoplankton deficiency.

Taipale SJ, Galloway AW, Aalto SL, Kahilainen KK, Strandberg U, Kankaala P.

Sci Rep. 2016 Aug 11;6:30897. doi: 10.1038/srep30897.

10.

Bacterial community response to changes in a tri-trophic cascade during a whole-lake fish manipulation.

Saarenheimo J, Aalto SL, Syväranta J, Devlin SP, Tiirola M, Jones RI.

Ecology. 2016 Mar;97(3):684-93.

PMID:
27197395
11.

A three-way perspective of stoichiometric changes on host-parasite interactions.

Aalto SL, Decaestecker E, Pulkkinen K.

Trends Parasitol. 2015 Jul;31(7):333-40. doi: 10.1016/j.pt.2015.04.005. Epub 2015 May 12. Review.

PMID:
25978937
12.

Active galaxies. A strong magnetic field in the jet base of a supermassive black hole.

Martí-Vidal I, Muller S, Vlemmings W, Horellou C, Aalto S.

Science. 2015 Apr 17;348(6232):311-4. doi: 10.1126/science.aaa1784.

13.

Intravenous ethanol increases dopamine release in the ventral striatum in humans: PET study using bolus-plus-infusion administration of [(11)C]raclopride.

Aalto S, Ingman K, Alakurtti K, Kaasinen V, Virkkala J, Någren K, Rinne JO, Scheinin H.

J Cereb Blood Flow Metab. 2015 Mar;35(3):424-31. doi: 10.1038/jcbfm.2014.209. Epub 2014 Dec 10.

14.

Food stoichiometry affects the outcome of Daphnia-parasite interaction.

Aalto SL, Pulkkinen K.

Ecol Evol. 2013 May;3(5):1266-75. doi: 10.1002/ece3.545. Epub 2013 Apr 2.

15.

Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.

Koivunen J, Karrasch M, Scheinin NM, Aalto S, Vahlberg T, Någren K, Helin S, Viitanen M, Rinne JO.

Dement Geriatr Cogn Disord. 2012;34(1):31-7. doi: 10.1159/000341580. Epub 2012 Aug 3.

PMID:
22868352
16.

Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.

Hagelberg N, Aalto S, Tuominen L, Pesonen U, Någren K, Hietala J, Scheinin H, Pertovaara A, Martikainen IK.

Neurosci Lett. 2012 Jul 11;521(1):11-4. doi: 10.1016/j.neulet.2012.05.042. Epub 2012 May 20.

PMID:
22622175
17.

Returning from oblivion: imaging the neural core of consciousness.

Långsjö JW, Alkire MT, Kaskinoro K, Hayama H, Maksimow A, Kaisti KK, Aalto S, Aantaa R, Jääskeläinen SK, Revonsuo A, Scheinin H.

J Neurosci. 2012 Apr 4;32(14):4935-43. doi: 10.1523/JNEUROSCI.4962-11.2012.

18.

Early detection of Alzheimer disease: ¹¹C-PiB PET in twins discordant for cognitive impairment.

Scheinin NM, Aalto S, Kaprio J, Koskenvuo M, Räihä I, Rokka J, Hinkka-Yli-Salomäki S, Rinne JO.

Neurology. 2011 Aug 2;77(5):453-60. doi: 10.1212/WNL.0b013e318225118e. Epub 2011 Jun 22.

PMID:
21700581
19.

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

Koivunen J, Scheinin N, Virta JR, Aalto S, Vahlberg T, Någren K, Helin S, Parkkola R, Viitanen M, Rinne JO.

Neurology. 2011 Mar 22;76(12):1085-90. doi: 10.1212/WNL.0b013e318212015e. Epub 2011 Feb 16.

PMID:
21325653
20.

Delta entropy of heart rate variability along with deepening anesthesia.

Mäenpää M, Laitio T, Kuusela T, Penttilä J, Kaisti K, Aalto S, Hinkka-Yli-Salomäki S, Scheinin H.

Anesth Analg. 2011 Mar;112(3):587-92. doi: 10.1213/ANE.0b013e318208074d. Epub 2011 Jan 13.

PMID:
21233497
21.

[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.

Jokinen P, Scheinin N, Aalto S, Någren K, Savisto N, Parkkola R, Rokka J, Haaparanta M, Röyttä M, Rinne JO.

Parkinsonism Relat Disord. 2010 Dec;16(10):666-70. doi: 10.1016/j.parkreldis.2010.08.021. Epub 2010 Sep 25.

PMID:
20870446
22.

Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET.

Hirvonen J, Hietala J, Kajander J, Markkula J, Rasi-Hakala H, Salminen JK, Någren K, Aalto S, Karlsson H.

J Psychopharmacol. 2011 Oct;25(10):1329-36. doi: 10.1177/0269881110376691. Epub 2010 Sep 9.

PMID:
20829308
23.

Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.

Alakurtti K, Aalto S, Johansson JJ, Någren K, Tuokkola T, Oikonen V, Laine M, Rinne JO.

J Cereb Blood Flow Metab. 2011 Jan;31(1):155-65. doi: 10.1038/jcbfm.2010.64. Epub 2010 May 5.

24.

Visual assessment of [(11)C]PIB PET in patients with cognitive impairment.

Suotunen T, Hirvonen J, Immonen-Räihä P, Aalto S, Lisinen I, Arponen E, Teräs M, Koski K, Sulkava R, Seppänen M, Rinne JO.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1141-7. doi: 10.1007/s00259-010-1382-8. Epub 2010 Feb 9.

PMID:
20143064
25.

Research letter: Psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder.

Karlsson H, Hirvonen J, Kajander J, Markkula J, Rasi-Hakala H, Salminen JK, Någren K, Aalto S, Hietala J.

Psychol Med. 2010 Mar;40(3):523-8. doi: 10.1017/S0033291709991607. Epub 2009 Nov 11. No abstract available.

PMID:
19903365
26.

The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study.

Vilkman H, Kajander J, Aalto S, Vahlberg T, Någren K, Allonen T, Syvälahti E, Hietala J.

Psychiatry Res. 2009 Nov 30;174(2):130-7. doi: 10.1016/j.pscychresns.2009.04.006.

PMID:
19846281
27.

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.

Scheinin NM, Aalto S, Koikkalainen J, Lötjönen J, Karrasch M, Kemppainen N, Viitanen M, Någren K, Helin S, Scheinin M, Rinne JO.

Neurology. 2009 Oct 13;73(15):1186-92. doi: 10.1212/WNL.0b013e3181bacf1b. Epub 2009 Sep 2.

PMID:
19726751
28.

Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia.

Martelius T, Lappalainen M, Aalto SM, Nihtinen A, Hedman K, Anttila VJ.

Clin Microbiol Infect. 2010 Jun;16(6):657-62. doi: 10.1111/j.1469-0691.2009.02922.x. Epub 2009 Aug 20.

29.

Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.

Aalto S, Scheinin NM, Kemppainen NM, Någren K, Kailajärvi M, Leinonen M, Scheinin M, Rinne JO.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1651-60. doi: 10.1007/s00259-009-1174-1. Epub 2009 Jun 4.

PMID:
19495749
30.

A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen.

Brück A, Aalto S, Rauhala E, Bergman J, Marttila R, Rinne JO.

Mov Disord. 2009 May 15;24(7):1009-15. doi: 10.1002/mds.22484.

PMID:
19260097
31.

The effects of xenon anesthesia on the relationship between cerebral glucose metabolism and blood flow in healthy subjects: a positron emission tomography study.

Laitio RM, Långsjö JW, Aalto S, Kaisti KK, Salmi E, Maksimow A, Aantaa R, Oikonen V, Viljanen T, Parkkola R, Scheinin H.

Anesth Analg. 2009 Feb;108(2):593-600. doi: 10.1213/ane.0b013e31818ffc9d.

PMID:
19151294
32.

Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation.

Tenovuo O, Kemppainen N, Aalto S, Någren K, Rinne JO.

J Alzheimers Dis. 2008 Nov;15(3):351-5.

PMID:
18997288
33.

The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.

Aalto S, Hirvonen J, Kaasinen V, Hagelberg N, Kajander J, Någren K, Seppälä T, Rinne JO, Scheinin H, Hietala J.

Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):475-83. doi: 10.1007/s00259-008-0969-9. Epub 2008 Nov 5.

PMID:
18985345
34.

Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease.

Virta JJ, Aalto S, Järvenpää T, Karrasch M, Kaprio J, Koskenvuo M, Räihä I, Viljanen T, Rinne JO.

J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):259-66. doi: 10.1136/jnnp.2008.145466. Epub 2008 Oct 31.

PMID:
18977818
35.

PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment.

Koivunen J, Pirttilä T, Kemppainen N, Aalto S, Herukka SK, Jauhianen AM, Hänninen T, Hallikainen M, Någren K, Rinne JO, Soininen H.

Dement Geriatr Cogn Disord. 2008;26(4):378-83. doi: 10.1159/000163927. Epub 2008 Oct 16.

PMID:
18931497
36.

Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects.

Hirvonen J, Aalto S, Hagelberg N, Maksimow A, Ingman K, Oikonen V, Virkkala J, Någren K, Scheinin H.

Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):275-86. doi: 10.1007/s00259-008-0935-6. Epub 2008 Sep 9.

PMID:
18779961
37.

Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study.

Salminen JK, Karlsson H, Hietala J, Kajander J, Aalto S, Markkula J, Rasi-Hakala H, Toikka T.

Psychother Psychosom. 2008;77(6):351-7. doi: 10.1159/000151388. Epub 2008 Aug 14.

PMID:
18701831
38.

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Någren K, Tapiola T, Pirttilä T, Rinne J, Jääskeläinen JE, Soininen H, Rinne JO.

Arch Neurol. 2008 Oct;65(10):1304-9. doi: 10.1001/archneur.65.10.noc80013. Epub 2008 Aug 11.

PMID:
18695050
39.

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.

Koivunen J, Verkkoniemi A, Aalto S, Paetau A, Ahonen JP, Viitanen M, Någren K, Rokka J, Haaparanta M, Kalimo H, Rinne JO.

Brain. 2008 Jul;131(Pt 7):1845-53. doi: 10.1093/brain/awn107. Epub 2008 Jun 25.

PMID:
18583368
40.

Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.

Jokinen P, Brück A, Aalto S, Forsback S, Parkkola R, Rinne JO.

Parkinsonism Relat Disord. 2009 Feb;15(2):88-93. doi: 10.1016/j.parkreldis.2008.03.005. Epub 2008 Apr 22.

PMID:
18434233
41.

Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.

Remes AM, Laru L, Tuominen H, Aalto S, Kemppainen N, Mononen H, Någren K, Parkkola R, Rinne JO.

Arch Neurol. 2008 Apr;65(4):540-4. doi: 10.1001/archneur.65.4.540.

PMID:
18413480
42.

Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.

Salmi E, Aalto S, Hirvonen J, Långsjö JW, Maksimow AT, Oikonen V, Metsähonkala L, Virkkala J, Någren K, Scheinin H.

Neuroimage. 2008 Jun;41(2):260-9. doi: 10.1016/j.neuroimage.2008.02.035. Epub 2008 Mar 4.

PMID:
18411060
43.

Xenon does not affect gamma-aminobutyric acid type A receptor binding in humans.

Salmi E, Laitio RM, Aalto S, Maksimow AT, Långsjö JW, Kaisti KK, Aantaa R, Oikonen V, Metsähonkala L, Någren K, Korpi ER, Scheinin H.

Anesth Analg. 2008 Jan;106(1):129-34, table of contents. doi: 10.1213/01.ane.0000287658.14763.13.

PMID:
18165567
44.

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.

Kemppainen NM, Aalto S, Karrasch M, Någren K, Savisto N, Oikonen V, Viitanen M, Parkkola R, Rinne JO.

Ann Neurol. 2008 Jan;63(1):112-8.

PMID:
18023012
45.

Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients.

Aalto SM, Juvonen E, Tarkkanen J, Volin L, Haario H, Ruutu T, Hedman K.

Clin Infect Dis. 2007 Nov 15;45(10):1305-9. Epub 2007 Oct 15.

PMID:
17968825
46.

Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait.

Lyoo CH, Aalto S, Rinne JO, Lee KO, Oh SH, Chang JW, Lee MS.

Mov Disord. 2007 Nov 15;22(15):2176-82.

PMID:
17712844
47.

Dopamine D2/D3 receptor binding in the anterior cingulate cortex and executive functioning.

Lumme V, Aalto S, Ilonen T, Någren K, Hietala J.

Psychiatry Res. 2007 Oct 15;156(1):69-74. Epub 2007 Aug 1.

PMID:
17683918
48.

Retrospective evaluation of serum Epstein Barr virus DNA levels in 406 allogeneic stem cell transplant patients.

Juvonen E, Aalto S, Tarkkanen J, Volin L, Hedman K, Ruutu T.

Haematologica. 2007 Jun;92(6):819-25.

49.

Effects of xenon anesthesia on cerebral blood flow in humans: a positron emission tomography study.

Laitio RM, Kaisti KK, Låangsjö JW, Aalto S, Salmi E, Maksimow A, Aantaa R, Oikonen V, Sipilä H, Parkkola R, Scheinin H.

Anesthesiology. 2007 Jun;106(6):1128-33.

PMID:
17525587
50.

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO.

Neurology. 2007 May 8;68(19):1603-6.

PMID:
17485647

Supplemental Content

Support Center